ConductScience.org, home

Paper3203043

The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man.

van Harten J and 4 others. Br J Clin Pharmacol, 1988. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man. Papers, record 3203043. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3203043

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
1.66
iCite
Revised in PubMed
2019-05-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1van Harten JJ
2van Brummelen PP
3Zeegers RRR R
4Danhof MM
5Breimer DDD D

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HemodynamicsMajor topic
NifedipineMajor topic
Vasodilator AgentsMajor topic
Adsorption
Adult
Female
Humans
Indocyanine Green
Infusions, Intravenous
Liver Circulation
Male
Nisoldipine

Source PubMed

Download CSV of topics

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17097514Model-independent steady-state volume of distribution.J Pharm Sci1982https://conductscience.org/library/papers/7097514PubMed
23443667Gas chromatographic determination of nisoldipine and one of its metabolites in plasma.J Chromatogr1987https://conductscience.org/library/papers/3443667PubMed
36419762Nifedipine increases and glyceryl trinitrate decreases apparent liver blood flow in normal subjects.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6419762PubMed
46491984Effects of hemodynamic changes on the elimination kinetics of verapamil and nifedipine.J Pharmacol Exp Ther1984https://conductscience.org/library/papers/6491984PubMed
56518345Energy conservation by nisoldipine in ischaemic heart.Br J Pharmacol1984https://conductscience.org/library/papers/6518345PubMed
63968639Effects of nisoldipine on cardiocirculatory dynamics and cardiac output distribution in conscious rats at rest and during treadmill exercise.J Pharmacol Exp Ther1985https://conductscience.org/library/papers/3968639PubMed
73894474A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects.J Am Coll Cardiol1985https://conductscience.org/library/papers/3894474PubMed
84025130Salutary hemodynamic and sustained clinical beneficial effects of nisoldipine, a new calcium channel blocker, in patients with recurrent ischemia and severe heart failure.Am Heart J1985https://conductscience.org/library/papers/4025130PubMed
94041329Verapamil pharmacokinetics and apparent hepatic and renal blood flow.Br J Clin Pharmacol1985https://conductscience.org/library/papers/4041329PubMed
104041344The effect of nisoldipine on apparent liver blood flow and effective renal plasma flow.Br J Clin Pharmacol1985https://conductscience.org/library/papers/4041344PubMed
114054203The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/4054203PubMed
123958095Determination of nimodipine by gas chromatography using electron-capture detection; external factors influencing nimodipine concentrations during intravenous administration.J Chromatogr1986https://conductscience.org/library/papers/3958095PubMed
133731687Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy.Clin Pharmacol Ther1986https://conductscience.org/library/papers/3731687PubMed
143802702Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans.Clin Pharmacol Ther1987https://conductscience.org/library/papers/3802702PubMed
153606929Pharmacokinetics and pharmacodynamics of nifedipine infusion in normal volunteers.Br J Clin Pharmacol1987https://conductscience.org/library/papers/3606929PubMed
166684444Hemodynamic effects of nisoldipine in chronic congestive heart failure.Arzneimittelforschung1983https://conductscience.org/library/papers/6684444PubMed

Download CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
24735761Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.J Pharm Pharm Sci2014https://conductscience.org/library/papers/24735761PubMed
9833602The influence of drug input rate on the development of tolerance to frusemide.Br J Clin Pharmacol1998https://conductscience.org/library/papers/9833602PubMed
9784933Clinical pharmacokinetics of nisoldipine coat-core.Clin Pharmacokinet1998https://conductscience.org/library/papers/9784933PubMed
8162657Influence of drug formulation on drug concentration-effect relationships.Clin Pharmacokinet1994https://conductscience.org/library/papers/8162657PubMed
8145128A mathematical model for dynamics of cardiovascular drug action: application to intravenous dihydropyridines in healthy volunteers.J Pharmacokinet Biopharm1993https://conductscience.org/library/papers/8145128PubMed
8005183Influence of input rates on (+/-)-isradipine haemodynamics and concentration-effect relationship in healthy volunteers.Eur J Clin Pharmacol1994https://conductscience.org/library/papers/8005183PubMed
3065058
Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
Drugs1988https://conductscience.org/library/papers/3065058PubMed
2757881The contribution of nisoldipine-induced changes in liver blood flow to its pharmacokinetics after oral administration.Br J Clin Pharmacol1989https://conductscience.org/library/papers/2757881PubMed
2706880Influence of renal function on the pharmacokinetics and cardiovascular effects of nisoldipine after single and multiple dosing.Clin Pharmacokinet1989https://conductscience.org/library/papers/2706880PubMed
2488100Calcium channel antagonists: Part VI: Clinical pharmacokinetics of first and second-generation agents.Cardiovasc Drugs Ther1989https://conductscience.org/library/papers/2488100PubMed
2181524The use of kinetic-dynamic interactions in the evaluation of drugs.Psychopharmacology (Berl)1990https://conductscience.org/library/papers/2181524PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3203043

GET https://conductscience.org/api/papers/v1/3203043/authors